Inhibitory effect of glucocorticoids on human-cloned 5- hydroxytryptamine3A receptor expressed in xenopus oocytes

Anesthesiology

Volumn 101, Issue 3, 2004, Pages 660-665

  Suzuki, Takahiro ^a   Sugimoto, Masahiro ^a   Koyama, Hideki ^a   Mashimo, Takashi ^a   Uchida, Ichiro ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; METHYLPREDNISOLONE; METOCLOPRAMIDE; RAMOSETRON; RECEPTOR SUBTYPE; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN 3A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; DRUG POTENTIATION; INHIBITION KINETICS; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; XENOPUS LAEVIS;

EID: 4344681196     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200409000-00014     Document Type: Article

References (34)

1. 3 receptor channel. Annu Rev Physiol 1995; 57:447-68
2. Orteils MO, Lunt GG: Evolutionary history of the ligand-gated ion-channel superfamily of receptors. Trends Neurosci 1995; 18:121-7
3. Arpels JC: The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause: A hypothesis and review of supporting data. J Reprod Med 1996; 41:633-9
4. A receptor function through distinct sites. Brain Res 1999; 830:72-87
5. A receptor-mediated currents via a reduction of channel opening frequency. Brain Res 1989; 489:190-4
6. A-receptor complexes in the guinea pig isolated ileum. Neurosci Lett 1987; 82:101-6
7. Bouzat C, Barrantes FJ: Modulation of muscle nicotinic acetylcholine receptors by the glucocorticoid hydrocortisone. J Biol Chem 1996; 271:25835-41
8. Kindler CH, Verotta D, Gray AT, Gropper MA, Yost S: Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium. ANESTHESIOLOGY 2000; 92:821-32
9. 3 receptor of N1E-115 neuroblastoma cells. Naunyn-Schmied Arch Pharmacol 1999; 360:234-41
10. Wetzel CHR, Hermann B, Behl C, Pestel E, Rammes G, Zieglgänsberger W, Holsboer F, Rupprecht R: Functional antagonism of gonadal steroids at the 5-Hydroxytryptamine type 3 receptor. Mol Endocrinol 1998; 12:1441-51
11. Kris MG, Gralla RJ, Tyson LB, Clark RA, Cirrincione C, Groshen S: Controlling delayed vomiting: double-blind randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol 1989; 7:108-14
12. Rich W, Abdulhayoglu G, DiSajia PJ: Methylprednisolone as antiemetic during cancer chemotherapy: A pilot study. Gynecol Oncol 1980; 9:193-8
13. Henzi I, Walder B, Tramer MR: Dexamethasone for the prevention of postoperative nausea and vomiting: A quantitative systematic review. Anesth Analgb 2000; 90:186-94
14. Yarker YE, McTavish D: Granisetron: An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy. Drugs 1994; 48:761-93
15. Schmoll HJ, Casper J: Management of other non-induced cisplatin-induced emesis. Oncology 1996; 53(suppl 1):51-5
16. Sadhasivam S, Shende D, Madan R: Prophylactic ondansetron in prevention of postoperative nausea and vomiting following pediatric strabismus surgery: A dose-response study. ANESTHESIOLOGY 2000; 92:1035-42
17. Fujii Y, Saitoh Y, Tanaka H, Toyooka H: Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery. Anesth Analg 2000; 90:472-5
18. Janknegt R, Pinckaers JWM, Rohof MHC, Ausems MEM, Arbouw MEL, van der Velden RW, Brouwers JRBJ: Double-blind comparative study of droperidol, granisetron and granisetron plus dexamethasone as prophylactic anti-emetic therapy in patients undergoing abdominal, gynaecological, breast or otolaryngological surgery. Anaesthesia 1999; 54:1059-68
19. Smith D, Newlands E, Rustin G, Begent RHJ, Howells N, McQuade B, Bagshawe KD: Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 1991; 338:487-90
20. 3 receptor antagonists for chemotherapy-induced nausea and vomiting. Cancer J 1998; 2:72-7
21. 3 receptor: Heterogeneity in distribution and function among species. Mol Pharmacol 1995; 48:407-16
22. Uki M, Nabekura J, Akaike N: Suppression of the nicotinic acetylcholine response in rat superior cervical ganglionic neurons by steroids. J Neurochem 1999; 72:808-14
23. Wong M, Moss RL: Patch-clamp analysis of direct steroidal modulation of glutamate receptor-channels. J Neuroendocrinol 1994; 6:347-55
24. Jaghoubi N, Malayev A, Russek SJ, Gibbs TT, Farb DH: Neurosteroid modulation of recombinant ionotropic glutamate receptors. Brain Res 1998; 803:153-60
25. Werkman TR, Van der Linden S, Joels M: Corticosteroid effects on sodium and calcium currents in acutely dissociated rat CA1 hippocampal neurons. Neuroscience 1997; 78:663-72
26. Zakon HH: The effects of steroid hormones on electrical activity of excitable cells. Trends Neurosci 1998; 21:202-7
27. Boess FG, Martin IL: Molecular biology of 5-HT receptors. Neurophamacology 1994; 33:275-317
28. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 1988; 240:889-95
29. Rupprecht R, Reul JMHM, Trapp T, van Steensel B, Wetzel C, Damm K, Zieglgänsberger W, Holsboer F: Progesterone receptor-mediated effects of neuroactive steroids. Neuron 1993; 11:523-30
30. Tsuei SE, Moore G, Ashley JJ, McBride WG: Disposition of synthetic glucocorticoids: Pharmacokinetics of dexamethasone in healthy adults. J Pharmacokin Biopharm 1979; 7:249-64
31. Braughler JM, Hall ED: Uptake and elimination of methylprednisolone from contused cat spinal cord following intravenous injection of the sodium succinate ester. J Neurosurg 1983; 58:538-42
32. 3 receptor of N1E-115 neuroblastoma cells. Naunyn-Schmied Arch Pharmacol 1993; 347:125-32
33. Tang J, Chen X, White PF, Wender RH, Ma H, Sloninsky A, Naruse R, Kariger R, Webb T, Zaentz A: Antiemetic prophylaxis for office-based surgery: Are the 5-HT3 receptor antagonists beneficial? ANESTHESIOLOGY 2003; 98:293-8
34. Harmon D, O'Connor P, Gleasa O, Gardiner J: Menstrual cycle irregularity and the incidence of nausea and vomiting after laparoscopy. Anaesthesia 2000; 55:1164-7